PLUS1
151.15
-0.38 (-0.25%)
-0.38 (-0.25%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 1,938,750 |
|
|||||
| News | - | ||||||
| Day High | 151.90 | Low High |
|||||
| Day Low | 151.10 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Biohaven Ltd | BHVN | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.38 | -0.25% | 151.15 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 151.75 | 151.10 | 151.90 | 151.17 | 151.53 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 21,849 | 1,938,750 | $ 151.59 | $ 293,898,428 | - | 79.01 - 152.56 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 123,741 | $ 151.17 | USD |
Period:
Draw Mode:
Biohaven Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 10.83B | 71.65M | 64.56M | $ 462.51M | $ -359.05M | -13.13 | -10.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 38.00k | 9.20% |
Biohaven News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BHVN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 151.24 | 152.56 | 151.00 | 151.85 | 2,196,246 | -0.09 | -0.06% |
| 1 Month | 149.99 | 152.56 | 149.30 | 151.33 | 1,183,722 | 1.16 | 0.77% |
| 3 Months | 145.18 | 152.56 | 144.72 | 149.20 | 723,046 | 5.97 | 4.11% |
| 6 Months | 121.63 | 152.56 | 79.01 | 138.26 | 1,253,116 | 29.52 | 24.27% |
| 1 Year | 133.00 | 152.56 | 79.01 | 133.65 | 916,089 | 18.15 | 13.65% |
| 3 Years | 41.57 | 152.56 | 26.56 | 94.81 | 759,731 | 109.58 | 263.6% |
| 5 Years | 26.85 | 152.56 | 16.5001 | 77.38 | 667,488 | 124.30 | 462.94% |
Biohaven Description
| Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others. |
